C. Gregory Peters
Stock Analyst at Raymond James
(4.75)
# 106
Out of 4,754 analysts
199
Total ratings
72.83%
Success rate
14.61%
Average return
Main Sectors:
Stocks Rated by C. Gregory Peters
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HQY HealthEquity | Maintains: Outperform | $105 → $120 | $109.76 | +9.33% | 11 | Feb 25, 2025 | |
| MCY Mercury General | Upgrades: Strong Buy | $70 → $80 | $53.93 | +48.34% | 6 | Feb 12, 2025 | |
| MMC Marsh & McLennan Companies | Reiterates: Outperform | $240 → $250 | $237.84 | +5.11% | 17 | Feb 6, 2025 | |
| KMPR Kemper | Maintains: Strong Buy | $75 → $82 | $67.58 | +21.34% | 13 | Dec 26, 2024 | |
| HGTY Hagerty | Downgrades: Underperform | n/a | $10.12 | - | 2 | Dec 26, 2024 | |
| PGR The Progressive Corporation | Upgrades: Outperform | $305 | $282.00 | +8.16% | 20 | Dec 26, 2024 | |
| WTW Willis Towers Watson | Upgrades: Strong Buy | $365 → $400 | $339.65 | +17.77% | 10 | Dec 5, 2024 | |
| ACIC American Coastal Insurance | Maintains: Outperform | $15 → $16 | $12.14 | +31.80% | 2 | Nov 12, 2024 | |
| SKWD Skyward Specialty Insurance Group | Maintains: Strong Buy | $45 → $55 | $52.02 | +5.73% | 8 | Nov 5, 2024 | |
| ALL The Allstate Corporation | Maintains: Strong Buy | $205 → $220 | $199.15 | +10.47% | 23 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $95 → $110 | $118.54 | -7.20% | 10 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Strong Buy | $40 → $45 | $41.14 | +9.38% | 1 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $100 → $120 | $118.28 | +1.45% | 6 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $270 → $285 | $285.48 | -0.17% | 8 | Feb 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $220 → $245 | $258.49 | -5.22% | 7 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $337.74 | - | 18 | Dec 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $455 → $460 | $353.22 | +30.23% | 1 | Nov 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $255 → $260 | $296.91 | -12.43% | 8 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $29 → $30 | $38.51 | -22.10% | 8 | Oct 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $409.12 | - | 7 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $147.81 | - | 1 | Sep 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $76.09 | - | 1 | Jun 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $60 → $67 | $109.47 | -38.80% | 2 | Feb 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $14.49 | - | 4 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $42.33 | - | 1 | Feb 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $8.81 | - | 4 | Feb 1, 2021 |
HealthEquity
Feb 25, 2025
Maintains: Outperform
Price Target: $105 → $120
Current: $109.76
Upside: +9.33%
Mercury General
Feb 12, 2025
Upgrades: Strong Buy
Price Target: $70 → $80
Current: $53.93
Upside: +48.34%
Marsh & McLennan Companies
Feb 6, 2025
Reiterates: Outperform
Price Target: $240 → $250
Current: $237.84
Upside: +5.11%
Kemper
Dec 26, 2024
Maintains: Strong Buy
Price Target: $75 → $82
Current: $67.58
Upside: +21.34%
Hagerty
Dec 26, 2024
Downgrades: Underperform
Price Target: n/a
Current: $10.12
Upside: -
The Progressive Corporation
Dec 26, 2024
Upgrades: Outperform
Price Target: $305
Current: $282.00
Upside: +8.16%
Willis Towers Watson
Dec 5, 2024
Upgrades: Strong Buy
Price Target: $365 → $400
Current: $339.65
Upside: +17.77%
American Coastal Insurance
Nov 12, 2024
Maintains: Outperform
Price Target: $15 → $16
Current: $12.14
Upside: +31.80%
Skyward Specialty Insurance Group
Nov 5, 2024
Maintains: Strong Buy
Price Target: $45 → $55
Current: $52.02
Upside: +5.73%
The Allstate Corporation
Oct 4, 2024
Maintains: Strong Buy
Price Target: $205 → $220
Current: $199.15
Upside: +10.47%
Jul 25, 2024
Maintains: Outperform
Price Target: $95 → $110
Current: $118.54
Upside: -7.20%
May 22, 2024
Reiterates: Strong Buy
Price Target: $40 → $45
Current: $41.14
Upside: +9.38%
Apr 1, 2024
Reiterates: Outperform
Price Target: $100 → $120
Current: $118.28
Upside: +1.45%
Feb 1, 2024
Maintains: Strong Buy
Price Target: $270 → $285
Current: $285.48
Upside: -0.17%
Jan 22, 2024
Maintains: Strong Buy
Price Target: $220 → $245
Current: $258.49
Upside: -5.22%
Dec 12, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $337.74
Upside: -
Nov 20, 2023
Maintains: Strong Buy
Price Target: $455 → $460
Current: $353.22
Upside: +30.23%
Nov 2, 2023
Maintains: Outperform
Price Target: $255 → $260
Current: $296.91
Upside: -12.43%
Oct 30, 2023
Maintains: Outperform
Price Target: $29 → $30
Current: $38.51
Upside: -22.10%
Oct 31, 2022
Downgrades: Underperform
Price Target: n/a
Current: $409.12
Upside: -
Sep 23, 2022
Initiates: Market Perform
Price Target: n/a
Current: $147.81
Upside: -
Jun 7, 2022
Initiates: Market Perform
Price Target: n/a
Current: $76.09
Upside: -
Feb 7, 2022
Maintains: Outperform
Price Target: $60 → $67
Current: $109.47
Upside: -38.80%
Aug 12, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $14.49
Upside: -
Feb 19, 2021
Initiates: Market Perform
Price Target: n/a
Current: $42.33
Upside: -
Feb 1, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $8.81
Upside: -